Your browser doesn't support javascript.
loading
Thymine DNA glycosylase as a novel target for melanoma.
Mancuso, Pietro; Tricarico, Rossella; Bhattacharjee, Vikram; Cosentino, Laura; Kadariya, Yuwaraj; Jelinek, Jaroslav; Nicolas, Emmanuelle; Einarson, Margret; Beeharry, Neil; Devarajan, Karthik; Katz, Richard A; Dorjsuren, Dorjbal G; Sun, Hongmao; Simeonov, Anton; Giordano, Antonio; Testa, Joseph R; Davidson, Guillaume; Davidson, Irwin; Larue, Lionel; Sobol, Robert W; Yen, Timothy J; Bellacosa, Alfonso.
Afiliação
  • Mancuso P; Cancer Epigenetics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Tricarico R; Department of Medical Biotechnologies, Universita' degli Studi di Siena, Siena, Italy.
  • Bhattacharjee V; Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, 91405, Orsay, France.
  • Cosentino L; Cancer Epigenetics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Kadariya Y; Cancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Jelinek J; Cancer Epigenetics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Nicolas E; Cancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Einarson M; Fels Institute for Cancer and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, 19140, USA.
  • Beeharry N; Cancer Epigenetics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Devarajan K; Cancer Epigenetics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Katz RA; Cancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Dorjsuren DG; Department of Biostatistics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Sun H; Cancer Epigenetics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Simeonov A; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, 20850, USA.
  • Giordano A; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, 20850, USA.
  • Testa JR; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, 20850, USA.
  • Davidson G; Department of Medical Biotechnologies, Universita' degli Studi di Siena, Siena, Italy.
  • Davidson I; Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.
  • Larue L; Cancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Sobol RW; Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, 67404, Illkirch, France.
  • Yen TJ; Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, 67404, Illkirch, France.
  • Bellacosa A; Equipe Labellisée Ligue Contre le Cancer, Orsay, France.
Oncogene ; 38(19): 3710-3728, 2019 05.
Article em En | MEDLINE | ID: mdl-30674989
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Timina DNA Glicosilase / Inibidores Enzimáticos / Melanoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Timina DNA Glicosilase / Inibidores Enzimáticos / Melanoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article